agios pharmaceuticals inc
William G. Kaelin Jr., M.D.
Director, Member of Finance Committee and Member of Science & Technology Committee, Eli Lilly and Company
|Age||Total Calculated Compensation||This person is connected to 143 board members in 10 different organizations across 10 different industries.|
See Board Relationships
Dr. William G. Kaelin, Jr., MD is a Professor of Medicine at Harvard Medical School. Dr. Kaelin is a Professor at Dana-Farber Cancer Institute. He serves as an Investigator at Howard Hughes Medical Institute. Dr. Kaelin is involved with consultancy of several oncology companies. He has been a Member of Scientific Advisory Board at Syros Pharmaceuticals since April 2013. He has been Member of Scientific Advisory Board at Traversa Therapeutics, Inc. since March 2009. Dr. ...
38 Sidney StreetPhone: 617-649-8600
Cambridge, Massachusetts 02139
Board Members Memberships*
Director, Member of Finance Committee and Member of Science & Technology Committee
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|Robert A. Bradway||Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee|
|Lamberto Andreotti||Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee|
Bristol-Myers Squibb Company
|Erez Vigodman||Chief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee|
Teva Pharmaceutical Industries Limited
|Pascal Soriot||Chief Executive Officer, Executive Director and Member of Disclosure Committee|
|Richard A. Gonzalez||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|$1.5M||Compensation as of Fiscal Year 2013.|